In silico Platform for designing genome-based
Personalized immunotherapy or Vaccine against Cancer

Fully Personalized

Aim of this section is to analyse the mutated protein sequences of cancer sample/cell line for presence of mutations by comparing with the wild type sequence of same protein of same individual and provide the predicted immune information in the body. The term fully personalized denotes for the compare of query protein sequence with the wild type protein sequence of same individual in place of the reference proteome.

CANCERTOPE    |     Raghava's Group    |     IMTECH    |     CSIR    |     CRDD    |     GPSR Package